Reevaluation of reference values for bone marrow differential counts in 236 healthy bone marrow donors Stefani ParmentierMichael KramerFrank Kroschinsky Original Article Open access 15 September 2020 Pages: 2723 - 2729
Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel Idit PazgalVered YahalomPinhas Stark Original Article 02 June 2020 Pages: 2731 - 2736
Influence of rs1042713 and rs1042714 polymorphisms of β2-adrenergic receptor gene with erythrocyte cAMP in sickle cell disease patients from Odisha State, India Shalini SinhaBimal Prasad JitPadmalaya Das Original Article 11 September 2020 Pages: 2737 - 2745
Genetic research and clinical analysis of deletional Chinese Gγ+(Aγδβ)0 -thalassemia and Southeast Asian HPFH in South China Yuanjun WuQianyu YaoFubing Yu Original Article Open access 15 September 2020 Pages: 2747 - 2753
Eltrombopag is effective in patients with relapse/refractory aplastic anemia—report from a single center in China Jing RuanWei ZuoBing Han Original Article 17 September 2020 Pages: 2755 - 2761
Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting Cihan AyLeonard PerschyIngrid Pabinger Original Article Open access 11 September 2020 Pages: 2763 - 2771
Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients Emilia ScalzulliGioia ColafigliMassimo Breccia Original Article 28 May 2020 Pages: 2773 - 2777
Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis Marko LucijanicDavor GalusicRajko Kusec Original Article 29 August 2020 Pages: 2779 - 2785
Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia Hitoshi MinamiguchiHiroyuki Fujitaon behalf of the Japan Adult Leukemia Study Group Original Article 02 September 2020 Pages: 2787 - 2800
Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study Chong WeiXinxin CaoDaobin Zhou Original Article 13 May 2020 Pages: 2801 - 2809
A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment Zegeng ChenXiaojie FangTongyu Lin Original Article 25 September 2020 Pages: 2811 - 2819
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis M. PouyiourouA. Meyeron behalf of the East German Study Group for Hematology and Oncology (OSHO) Original Article 30 July 2020 Pages: 2821 - 2829
Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09) Sora KangHyungwoo ChoCheolwon Suh Original Article 28 September 2020 Pages: 2831 - 2836
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma Andrew DaviesPeter TraskWenxin Liu Original Article Open access 20 April 2020 Pages: 2837 - 2846
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma Haizhu ChenYan QinYuankai Shi Original Article 25 July 2020 Pages: 2847 - 2857
Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma Toshihiro MatsukawaKeito SutoNorth Japan Hematology Study Group (NJHSG) Original Article 24 September 2020 Pages: 2859 - 2868
Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma Charles MesguichCyrille HulinGerald Marit Original Article 19 September 2020 Pages: 2869 - 2880
Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen Aneta Szudy-SzczyrekRadosław MlakMarek Hus Original Article Open access 26 May 2020 Pages: 2881 - 2891
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma Takashi NagayamaMasahiro AshizawaYoshinobu Kanda Original Article 22 June 2020 Pages: 2893 - 2901
KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patients Salvatore PalmieriS. RoccoF. Ferrara Original Article 25 June 2020 Pages: 2903 - 2909
Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status Yue LuYan-Li ZhaoDao-Pei Lu Original Article 01 October 2020 Pages: 2911 - 2925
Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT Satoshi YamasakiJinichi MoriMasamitsu Yanada Original Article 17 September 2020 Pages: 2927 - 2937
Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia Liat Shargian-AlonOfir WolachMoshe Yeshurun Original Article 06 September 2020 Pages: 2939 - 2945
Borrelia burgdorferi mimicking central nervous system relapse in diffuse large B cell lymphoma Marcel NijlandMartijn BakkerWouter Plattel Letter to the Editor 15 April 2020 Pages: 2947 - 2948
Unique evolution of angioimmunoblastic T cell lymphoma to Epstein-Barr virus–positive plasma cell myeloma Thomas S. Y. ChanAlvin H. W. IpYok-Lam Kwong Letter to the Editor 09 June 2020 Pages: 2949 - 2952
IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection Carolina VillegasMaría PozaJ. Martinez-Lopez Letter to the Editor 25 June 2020 Pages: 2953 - 2956
Bone marrow coexistence of chronic lymphocytic leukemia and Langerhans cell sarcoma Magda ZanelliStefano RicciStefano Ascani Letter to the Editor 03 July 2020 Pages: 2957 - 2959
Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL) Elena GuillenEnrique Montagud-MarrahiLuis F. Quintana Letter to the Editor 29 August 2020 Pages: 2961 - 2962
Early-stage mantle cell lymphoma—a rare entity with special characteristics and needs for treatment Lena Spechton behalf of the International Lymphoma Radiation Oncology Group (ILROG) Letter to the Editor 10 September 2020 Pages: 2963 - 2964
Pediatric recurrent Rosai-Dorfman disease with germline heterozygous SLC29A3 and somatic MAP2K1 mutations Shruthi SuryaprakashAmy GeorgeSüreyya Savaşan Letter to the Editor 17 September 2020 Pages: 2965 - 2967
Rare synchronous co-existence of acute myeloid leukemia and hairy cell leukemia in a same patient Xiaofeng ShiQian JiangXiaodong Xi Letter to the Editor 14 September 2020 Pages: 2969 - 2971
Venetoclax monotherapy for cutaneous blastic plasmacytoid dendritic cell neoplasm Matthew SchwedeIrena T. TanGabriel N. Mannis Letter to the Editor 23 September 2020 Pages: 2973 - 2975
